- NBIO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
-
8-K Filing Data
Nascent Biotech (NBIO) 8-K25 Jan 23Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical TrialFinancial data
Company Profile